ClinicalTrials.Veeva

Menu

Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain (RESORB)

N

North American Science Associates Ltd.

Status

Enrolling

Conditions

Knee Osteoarthritis (Knee OA)

Treatments

Drug: Corticosteroid Injection
Device: genicular artery embolization

Study type

Interventional

Funder types

NETWORK
Industry

Identifiers

NCT06872567
US037031

Details and patient eligibility

About

Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection

Enrollment

126 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient has localized knee pain
  • Must be an appropriate candidate for arterial vascular access procedure

Exclusion criteria

  • Known sensitivity or allergy to implant materials
  • Unable or unwilling to comply with study requirements

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

126 participants in 2 patient groups

Control
Active Comparator group
Treatment:
Drug: Corticosteroid Injection
Device: GAE
Experimental group
Treatment:
Device: genicular artery embolization

Trial contacts and locations

1

Loading...

Central trial contact

Ziv J Haskal, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems